3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
6
Genitourinary
1
Gastrointestinal
1
Conditions
Prostatic Neoplasms
7
Motor Activity
5
Colorectal Neoplasms
2
Urinary Bladder Neoplasms
1
Rectal Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Head and Neck Neoplasms
1
Fatigue
1
Breast Neoplasms
1
Interventions
pembrolizumab
27
Docetaxel
20
Cyclophosphamide
18
Surveys and Questionnaires
15
Therapeutics
14
Radiotherapy
13
Paclitaxel
12
Psychiatric Rehabilitation
11
Early Intervention, Educational
11
Carboplatin
11
Standard of Care
10
olaparib
9
Zoledronic Acid
9
Specimen Handling
9
Radiosurgery
9
Magnetic Resonance Spectroscopy
9
Interviews as Topic
9
Gemcitabine
9
Trastuzumab
8
Methods
8
Fulvestrant
8
palbociclib
7
fludarabine
7
durvalumab
7
Taxes
7
Nivolumab
7
Fluorodeoxyglucose F18
7
Flow Cytometry
7
Educational Status
7
Blood Specimen Collection
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
High-Intensity Interval Training
×
Genitourinary
×
Clear all
NCT02473003
2023-12-21
Phys-Can
Uppsala University
Phase NA
Unknown
600 enrolled